Deans' stroke musings: Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, September 29, 2025

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

Getting them to 100% recovery would vastly improve their chances of maintaining mental functions after a stroke. So, SOLVE THAT PROBLEM! This description of research DOES NOTHING FOR SURVIVORS; YOURE FIRED!

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

ClinicalTrials.gov IDNCT06615973

SponsorNational Institute of Neurological Disorders and Stroke (NINDS)

Information Provided byRebecca F Gottesman, M.D.

Study Start (Estimated)2025-10-02

Primary Completion (Estimated) 2026-02-01

Study Completion (Estimated)2026-02-01

Enrollment (Estimated)450

Study TypeObservational

Last Update Posted2025-09-29

Study Overview

Brief Summary

Background: Stroke is the fifth leading cause of death in the United States. It is also a leading cause of disability. More than 70% of people who survive strokes have mental impairment or dementia. Medical factors, such as the severity of the stroke, affect whether a person will have mental impairment afterward. But social factors, such as education and ethnicity, seem to play a role as well. Researchers want to learn more about how social and lifestyle factors affect a persons chances of maintaining mental functions after a stroke.

Objective: To better understand how social and lifestyle factors affect the risk of mental impairment after a stroke. Eligibility: People aged 18 years and older who had a stroke and a brain scan while they were enrolled in NIH Study 01N0007 (Natural History of Stroke Study).

Design: Participants will have 1 study visit, by telephone. The call will last about 45 minutes. Participants will talk about their health since their stroke. They will answer questions about themselves. Topics will include: * Their race * Education * Ethnicity * Employment * Marital status * Residence address * Recent health history * Medical insurance They will have tests of their memory, attention, and language skills. They will repeat numbers and words forward and backward. Researchers will look at the data and imaging scans collected during participant s enrollment in NIH Study 01N0007. This data will include: * The hospital that first saw the participant at the time of their stroke. * The type of imaging that was first used then. * The primary diagnosis at admission. * Other medical details.

To learn more, visitClinicalTrials.gov